Open label extension studies: research or marketing?

被引：43
|
作者：
Taylor, GJ [1 ]
Wainwright, P
机构：
[1] Univ Bath, Sch Hlth, Res & Dev Support Unit, Bath BA1 3NG, Avon, England
[2] Kingston Univ, Fac Hlth & Social Care Sci, London, England
[3] St George Hosp, Sch Med, London, England
来源：
BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7516期
关键词：
D O I：
10.1136/bmj.331.7516.572
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：572 / 574
页数：3
相关论文
共 50 条
  • [41] MARKETING RESEARCH STUDIES IN A GROCERY CHAIN
    Applebaum, William
    Spears, Richard F.
    [J]. JOURNAL OF MARKETING, 1952, 17 (01): : 52 - 56
  • [42] Maximizing the value of the open label extension phase of randomized clinical trials
    Trachtman, Howard
    Coppo, Rosanna
    Saleem, Moin
    Mercer, Alex
    Komers, Radko
    [J]. JOURNAL OF NEPHROLOGY, 2023, 36 (06) : 1561 - 1563
  • [43] Open Label Extension Findings for a Trial of Propranolol in Autism Spectrum Disorder
    Beversdorf, David
    Ferguson, Bradley
    Hunter, Samantha
    Hirst, Kathy
    Lolli, Bridget
    Bellesheim, Katie
    Barton, Amy Underwood
    Muckerman, Julie
    Takahashi, Nicole
    Selders, Kimberly
    Holem, Ryan
    Sohl, Kristin
    Dyke, Peter
    Stichter, Janine
    Mazurek, Micah
    Kanne, Stephen
    [J]. NEUROLOGY, 2021, 96 (15)
  • [44] Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis
    Paik, Julie
    Albayda, Jemima
    Tiniakou, Eleni
    Purwin, Grazyna
    Koenig, Andrew
    Christopher-Stine, Lisa
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [45] Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension
    Glidden, David V.
    Amico, K. Rivet
    Liu, Albert Y.
    Hosek, Sybil G.
    Anderson, Peter L.
    Buchbinder, Susan P.
    McMahan, Vanessa
    Mayer, Kenneth H.
    David, Burns
    Schechter, Mauro
    Grinsztejn, Beatriz
    Guanira, Juan
    Grant, Robert M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 62 (09) : 1172 - 1177
  • [46] New lessons for an old problem: ASSET open-label extension
    Del Galdo, Francesco
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (12): : E726 - E727
  • [47] Maximizing the value of the open label extension phase of randomized clinical trials
    Howard Trachtman
    Rosanna Coppo
    Moin Saleem
    Alex Mercer
    Radko Komers
    [J]. Journal of Nephrology, 2023, 36 : 1561 - 1563
  • [48] POULTRY PRODUCTS MARKETING - AN IMPORTANT PHASE OF TEACHING, EXTENSION, AND RESEARCH
    TERMOHLEN, WD
    [J]. POULTRY SCIENCE, 1947, 26 (05) : 556 - 557
  • [49] WELFARE IMPLICATIONS OF EFFICIENCY AND TECHNOLOGICAL IMPROVEMENTS IN MARKETING RESEARCH AND EXTENSION
    Witt, Lawrence
    [J]. JOURNAL OF FARM ECONOMICS, 1955, 37 (05): : 912 - 927
  • [50] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8
    Pope, Janet
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Haraoui, Boulos
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 879 - 879
12345